Roy Demands Answers On Mifepristone Study, Seeks To End Federal Abortion Funding
Earlier this year, Roy offered an amendment that sought to prohibit federal funds from being used to implement, administer, or enforce the FDA’s January 2023 changes to the mifepristone REMS